SEC Form 4 · accession 0001209191-17-005689
INNOVATE BIOPHARMACEUTICALS, INC. · INNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan P Clark
Officer — Interim President · Director
Period of report
Jan 24, 2017
Accepted (ET)
Jan 26, 2017 · 2:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551986
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 24, 2017 | A | 240,000 | $0.00 | A | 250,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Grant of restricted common stock pursuant to Issuer's 2012 Omnibus Incentive Plan.
- F2Shares of restricted common stock vest in full on one year anniversary of date of grant.